Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The “pre-mRNA or RNA–protein complexes of cardiac ion channels” refers to the messenger RNA transcripts of cardiac ion channel genes in their unspliced or partially spliced (pre-mRNA) form, along with the proteins (RNA-binding proteins, splicing factors) that associate with them to govern their processing, stability, and expression. These RNA-protein complexes regulate the amount and isoform diversity of sodium, potassium, and calcium ion channels crucial for cardiac electrical activity. Defects in pre-mRNA splicing or altered interactions with regulatory proteins can cause abnormal channel expression, contributing to arrhythmias and other cardiac diseases. The regulatory machinery and RNA-protein complexes are emerging drug targets, with the potential to correct pathological splicing or expression defects underlying inherited or acquired cardiac rhythm disorders[1][5].
Modulation of splicing (alternative splice-site selection) Regulation of mRNA stability and decay Alteration of translation efficiency
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac ion channel pre-mRNA or RNA–protein complex.